Skip to main content

Table 1 Characteristics of 10,266 KP Chronic Kidney Disease Enrollees and Univariate Associations With Type 2 Diabetes Status

From: Low documentation of chronic kidney disease among high-risk patients in a managed care population: a retrospective cohort study

Baseline Characteristics Total Cohort N = 10266 (100) (% or SD) Diabetic CKD N = 2508 (24.43)(% or SD) Non diabetic CKD N = 7758 (75.56) (% or SD) Odds Ratio (diabetic CKD vs non diabetic CKD) P value
Mean age (continuous) 63.06 (13.43) 63.50 (11.63) 62.92 (13.96) NA 0.0386
Mean eGFR* (continuous) 48.81 (10.11) 46.04 (11.46) 49.57 (9.52) NA < .0001
Men 4155 (40.47) 1111 (26.74) 3044 (73.26) 1.23 (1.12-1.34) < .0001
Hypertension 7916 (77.11) 2297 (29.02) 5619 (70.98) 4.14 (3.56-4.81) < .0001
eGFR 50-59 5868 (57.16) 1220 (20.79) 4648 (79.21) 1.00 (Referent) -
eGFR 40-49 2593 (25.26) 657 (25.34) 1936 (74.66) 1.29 (1.16-1.44) -
eGFR 30-49 1142 (11.12) 367 (32.14) 775 (67.86) 1.80 (1.57- 2.07) -
eGFR 20-39 457 (4.45) 171 (37.42) 286 (62.58) 2.27 (1.86- 2.78) -
eGFR 10-19 206 (2.01) 93 (45.15) 113 (54.85) 3.13 (2.36- 4.15) < 0.0001**
Coronary artery disease 1335 (13.00) 451 (33.78) 884 (66.22) 1.70 (1.50-1.92) < .0001
Chronic heart failure 750 (7.31) 293 (39.07) 457(60.93) 2.11 (1.81-2.46) < .0001
Cerebrovascular disease 163 (1.59) 62 (38.04) 101 (61.96) 1.92 (1.39-2.64) < .0001
Peripheral artery disease 490 (4.77) 253 (51.63) 237 (48.37) 3.56 (2.96-4.27) < .0001
ACEI use 1500 14.61) 631 (42.07) 869 (57.93) 2.66 (2.37-2.98) < .0001
ARB use 156 (1.52) 71 (45.51) 85 (54.49) 2.63 (1.91-3.61) < .0001
Statin use 1448 (14.10) 476 (32.87) 972 (67.13) 1.63 (1.45-1.84) < .0001
NSAID use 1213 (11.82) 228 (18.80) 985 (81.20) 0.68 (0.59-0.80) < .0001
  1. *eGFR in ml/min/1.73 m2; ** P value for trend